Skip to main content
Fig. 6 | Cancer Cell International

Fig. 6

From: Effects of RNA methylation N6-methyladenosine regulators on malignant progression and prognosis of melanoma

Fig. 6Fig. 6

Functional annotation of hub gene in human cancers. AC GSEA revealed the expression of IGF2BP3/ RBM15B/METTL16 was enriched for hallmarks of malignant tumors. D Trametinib and cobimetinib may exhibit sensitivity for melanoma with IGF2BP3 mutations, temsirolimus and XL-147 may exhibit sensitivity for melanoma with RBM15B mutations, gemcitabine and methotrexate may exhibit sensitivity for melanoma with METTL16 mutations (CellMiner)

Back to article page